- Home
- NTB vs WGS Comparison
NTB vs WGS Comparison
Compare NTB & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTB
- WGS
- Stock Information
- Founded
- NTB 1858
- WGS 2017
- Country
- NTB Bermuda
- WGS United States
- Employees
- NTB N/A
- WGS N/A
- Industry
- NTB Commercial Banks
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- NTB Finance
- WGS Technology
- Exchange
- NTB Nasdaq
- WGS Nasdaq
- Market Cap
- NTB 1.7B
- WGS 2.0B
- IPO Year
- NTB 2016
- WGS N/A
- Fundamental
- Price
- NTB $37.51
- WGS $79.66
- Analyst Decision
- NTB Buy
- WGS Strong Buy
- Analyst Count
- NTB 6
- WGS 5
- Target Price
- NTB $39.67
- WGS $67.00
- AVG Volume (30 Days)
- NTB 171.9K
- WGS 498.5K
- Earning Date
- NTB 02-10-2025
- WGS 10-29-2024
- Dividend Yield
- NTB 4.67%
- WGS N/A
- EPS Growth
- NTB N/A
- WGS N/A
- EPS
- NTB 4.50
- WGS N/A
- Revenue
- NTB $573,100,000.00
- WGS $267,228,000.00
- Revenue This Year
- NTB N/A
- WGS $43.70
- Revenue Next Year
- NTB N/A
- WGS $16.78
- P/E Ratio
- NTB $8.45
- WGS N/A
- Revenue Growth
- NTB N/A
- WGS 29.41
- 52 Week Low
- NTB $28.73
- WGS $1.76
- 52 Week High
- NTB $40.55
- WGS $89.11
- Technical
- Relative Strength Index (RSI)
- NTB 48.52
- WGS 57.88
- Support Level
- NTB $37.21
- WGS $70.69
- Resistance Level
- NTB $38.33
- WGS $83.53
- Average True Range (ATR)
- NTB 0.74
- WGS 5.91
- MACD
- NTB -0.00
- WGS -0.16
- Stochastic Oscillator
- NTB 43.38
- WGS 64.75
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, the Cayman Islands, the Channel Islands, and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.